About Cellugen Biotech Private Limited
Data last updated:
Cellugen Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 August 2008.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2008PTC182124. Its GSTIN is 06AADCB5451A1Z9 (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Unistem Biosciences Private Limited and Beike Biotech India Private Limited. It is led by directors Lalit Jaiswal and Kangan Jaiswal.
Its last annual general meeting (AGM) was held on 19 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Innov8 Coworking Salcon Rasvilas Lgf Next To Select City Walk Saket District Centre Saket District Sector 6 Pushp Vihar New Delhi – 110017., Delhi, India – 110017.
As per the financials filed for FY 2019, the company reported a revenue of ₹14.5 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.86 Lakh (net margin 0.7%) and EBITDA of ₹2.56 Cr (EBITDA margin 17.7%). Revenue has grown at a compounded annual rate (CAGR) of 84% over three years and 24% over five years.
The company is associated with 1 brand: CelluGen Biotech. As per MCA filings, the company has open charges of ₹5.67 Cr on record. Court records list 48 cases involving the company, including 3 filed by the company and 45 filed against it; 25 cases are pending.
The last known website on record is cellugen.in.
Company details
Name history
Cellugen Biotech has undergone 2 name changes throughout its history. The company was previously known as Unistem Biosciences Private Limited, and Beike Biotech India Private Limited. The current legal name is Cellugen Biotech Private Limited.
| Company Name | Status |
|---|---|
| Cellugen Biotech Private Limited | Current |
| Unistem Biosciences Private Limited | Previous |
| Beike Biotech India Private Limited | Previous |
Contact details
Cellugen Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is cellugen.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressInnov8 Coworking Salcon Rasvilas Lgf Next To Select City Walk Saket District Centre Saket District Sector 6 Pushp Vihar New Delhi – 110017., Delhi, India – 110017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cellugen Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cellugen Biotech operates one associated brand: CelluGen Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers cord blood banking services for medical and research purposes. | cellugen.in |
Business activity
The main business activity of Cellugen Biotech is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Cellugen Biotech Private Limited, buy the company report.
Financials of Cellugen Biotech Private Limited
FY 2019 filings availableCellugen Biotech Private Limited reported revenue of ₹14.5 Cr (up 4% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 4% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹14.5 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.56 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.7% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellugen Biotech Private Limited, buy the company report.
Board of directors of Cellugen Biotech Private Limited
Cellugen Biotech has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Jaiswal | Director | 18 Aug 2008 | 18 Years 2 Months | As last reported |
| Kangan Jaiswal Also directs: La Cellule Cosmetique Geneve Private Limited | Director | 25 Mar 2016 | 10 Years 6 Months | As last reported |
Auditor
Cellugen Biotech Private Limited is audited by SINGH SATISH AND ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH SATISH AND ASSOCIATES | FY 2019 | 032138N |
Shareholding
The shareholding of Cellugen Biotech Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cellugen Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Oct 2020 | 100384919 | Others | ₹66.53 Lakh | Open | |
| 25 Oct 2018 | 100213634 | Others | ₹5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Cellugen Biotech Private Limited has 48 court cases on record: 3 filed by Cellugen Biotech, 45 filed against it. 25 cases are pending and 23 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 45 | 45 | 23 |
| High courts | 3 | 0 | 2 |
Cases on record (5 of 48)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by Indusind Bank | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ecl Finance Limited. | Pending |
| District court, Gurugram, Haryana | Civil miscellaneous application | Filed against the company by Aar Vee Creations Pvt Ltd | Pending |
| High Court, HARYANA | Revision petition | Filed by the company against Aar Vee Creations Pvt. Ltd. and Ors. and 5 others | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Iifl Finance Limited | Pending |
To see the full case history of Cellugen Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellugen Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cellugen Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCB5451A1Z9 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cellugen Biotech Private Limited, buy the company report.
Recent activity
Cellugen Biotech Private Limited has 7 board changes on record since 2008: 2 appointments and 5 cessations. The latest: Kanishk Jaiswal ceased to be Director on 07 Apr 2022.
Frequently asked questions
Cellugen Biotech is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Cellugen Biotech is a company under insolvency, formerly operating as a private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 August 2008 and is registered under CIN U85110DL2008PTC182124. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Cellugen Biotech has 2 current directors:
- Lalit Jaiswal - Director
- Kangan Jaiswal - Director
The latest financial statements of Cellugen Biotech on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 19 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Cellugen Biotech is U85110DL2008PTC182124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellugen Biotech has open charges of ₹5.67 Cr and no satisfied charges on record as per latest MCA filings.
Cellugen Biotech has 48 court cases on record: 3 filed by the company and 45 filed against it. 25 are pending. Most are in the district courts.
Cellugen Biotech was incorporated on 18 August 2008. It is registered with the Registrar of Companies, Delhi.
Kanishk Jaiswal ceased to be Director on 07 Apr 2022. Kiran Jaiswal ceased to be Director on 07 Apr 2022. Umesh Arunbhai Yagnik ceased to be Director on 05 Jan 2022. Cellugen Biotech has 7 board changes on record in total.
Cellugen Biotech can be reached through the website cellugen.in. Its registered office is in New Delhi, Delhi, India.